GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Bioxyne Ltd (ASX:BXN) » Definitions » Cash from Discontinued Operating Activities

Bioxyne (ASX:BXN) Cash from Discontinued Operating Activities : A$0.00 Mil (TTM As of Jun. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Bioxyne Cash from Discontinued Operating Activities?

Cash from Discontinued Operating Activities is net cash from all of the entity's discontinued operating activities.

Bioxyne's Cash from Discontinued Operating Activities for the six months ended in Jun. 2024 was A$0.00 Mil. It means Bioxyne received A$0.00 Mil from discontinued investing activities. Bioxyne's Cash from Discontinued Operating Activities for the trailing twelve months (TTM) ended in Jun. 2024 was A$0.00 Mil.

Bioxyne Cash from Discontinued Operating Activities Historical Data

The historical data trend for Bioxyne's Cash from Discontinued Operating Activities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioxyne Cash from Discontinued Operating Activities Chart

Bioxyne Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Cash from Discontinued Operating Activities
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Bioxyne Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Cash from Discontinued Operating Activities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Bioxyne Cash from Discontinued Operating Activities Calculation

Cash from Discontinued Operating Activities is net cash from all of the entity's discontinued operating activities.

Cash from Discontinued Operating Activities for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioxyne Cash from Discontinued Operating Activities Related Terms

Thank you for viewing the detailed overview of Bioxyne's Cash from Discontinued Operating Activities provided by GuruFocus.com. Please click on the following links to see related term pages.

Bioxyne Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Bioxyne Ltd (ASX:BXN) » Definitions » Cash from Discontinued Operating Activities
Comparable Companies
ASX:AHF ASX:NOU ASX:JAT ASX:CLV ASX:WNX ASX:MBH ASX:CCO ASX:NUC ASX:BUB ASX:TFL XSWX:NESN XPAR:BN KHC SHSE:603288 GIS K SHSE:600887 SZSE:300999 NSE:NESTLEIND MKC
Traded in Other Exchanges
N/A
Address
50 Clarence Street, Suite 506, Level 5, Sydney, NSW, AUS, 2000
Website
https://www.bioxyne.com
Bioxyne Ltd is an Australian life science and health products company. The company is engaged in the development, manufacture, and distribution of consumer dietary supplements based on the proprietary probiotic strain of Lactobacillus fermentum PCC. Some of its products include Breathe Life Science, Dr Watson, BLS Clinics, Mirai Solution, CanXChange, and others. The company operates in segments namely, wholesale sales, Plant-based, Manufacturing sales, and direct sales. The majority of the revenue is generated from plants based segment.

Bioxyne Headlines

No Headlines